Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.01 USD | -1.38% | +4.59% | -0.79% |
Financials (USD)
Sales 2024 * | 76.38M | Sales 2025 * | 52.83M | Capitalization | 613M |
---|---|---|---|---|---|
Net income 2024 * | -119M | Net income 2025 * | -141M | EV / Sales 2024 * | 5.91 x |
Net cash position 2024 * | 161M | Net cash position 2025 * | 67.89M | EV / Sales 2025 * | 10.3 x |
P/E ratio 2024 * |
-4.96
x | P/E ratio 2025 * |
-4.69
x | Employees | 267 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.8% |
Latest transcript on Wave Life Sciences Ltd.
1 day | -1.38% | ||
1 week | +4.59% | ||
Current month | -18.80% | ||
1 month | -13.17% | ||
3 months | +13.86% | ||
6 months | -10.38% | ||
Current year | -0.79% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Bolno
CEO | Chief Executive Officer | 50 | 13-11-30 |
Kyle Moran
DFI | Director of Finance/CFO | 54 | 14-06-30 |
Chandra Vargeese
CTO | Chief Tech/Sci/R&D Officer | 63 | 14-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Christian Henry
CHM | Chairman | 56 | 16-11-09 |
Mark Corrigan
BRD | Director/Board Member | 66 | 19-09-03 |
Adrian Rawcliffe
BRD | Director/Board Member | 52 | 17-01-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +2.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 5.01 | -1.38% | 424,239 |
24-04-23 | 5.08 | +4.96% | 469,439 |
24-04-22 | 4.84 | -0.62% | 492,475 |
24-04-19 | 4.87 | +1.46% | 452,691 |
24-04-18 | 4.8 | +0.21% | 538,925 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.79% | 621M | |
-1.51% | 105B | |
+3.22% | 97.5B | |
+1.86% | 22.19B | |
-16.53% | 21.33B | |
-8.49% | 18.68B | |
-42.33% | 16.6B | |
-20.09% | 14.52B | |
+5.47% | 14.09B | |
+28.85% | 10.99B |
- Stock Market
- Equities
- WVE Stock